Syngene said that the FDA had reviewed its response and was satisfied with the company’s explanation and its plans for correcting the issues ...

In a filing made public on Saturday, the company said the inspection concluded with the U.S. regulator issuing Form 483, ...

Vedanta Ltd., led by Anil Agarwal, has scheduled a board meeting for Wednesday, June 18, where directors will review a proposal to declare an interim dividend for the ongoing financial year, FY26.